Understanding how the brain clears waste and its role in Alzheimer's disease

A mechanistic understanding of glymphatic transport and its implications in neurodegenerative disease

NIH-funded research University of Texas at Austin · NIH-10742654

This study is looking at how well the brain cleans out harmful waste, like proteins linked to Alzheimer's, to help us understand the disease better and find new ways to treat it.

Quick facts

Grant typeR21 grant
Study typeNIH-funded research
Funding institutionUniversity of Texas at Austin NIH-funded
Lab location1 site (Austin, United States)
Project IDNIH-10742654 on NIH RePORTER

What this research studies

This research investigates the glymphatic system, which is responsible for clearing waste from the brain, and its connection to neurodegenerative diseases like Alzheimer's. By using advanced imaging techniques and computational modeling, the study aims to quantify how effectively the brain removes harmful substances such as amyloid-beta and tau proteins. Patients may benefit from insights into how impaired waste clearance contributes to Alzheimer's, potentially leading to new treatment strategies. The research will involve detailed analysis of brain imaging data to create personalized models of glymphatic transport.

Who could benefit from this research

Good fit: Ideal candidates for this research are individuals diagnosed with Alzheimer's disease or those at risk of developing neurodegenerative conditions.

Not a fit: Patients with neurodegenerative diseases other than Alzheimer's or those without cognitive impairment may not benefit from this research.

Why it matters

Potential benefit: If successful, this research could lead to new therapeutic approaches that enhance waste clearance in the brain, potentially slowing the progression of Alzheimer's disease.

How similar studies have performed: While the glymphatic system is a relatively novel area of study, preliminary research has shown promise in understanding its role in neurodegeneration, indicating potential for impactful findings.

Where this research is happening

Austin, United States

Researchers

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions Alzheimer disease dementiaAlzheimer syndromeAlzheimer's Disease
Last reviewed 2026-06-13 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.